Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Pemvidutide (TFA) | 2538014-94-5 | 98.1% | C182H275N39O54.xC2HF3O2 | 25 MG
Supplier: Medchemexpress LLC 25MGHY145632A
Pemvidutide TFA (ALT-801) is a GLP-1R/GCGR dual agonist that causes significant reductions in body weight, liver fat, and serum lipids. It is used in non-alcoholic steatohepatitis (NASH) and obesity research.
- Causes striking reductions in body weight, liver fat, and serum lipids
- Applicable for research in non-alcoholic steatohepatitis (NASH) and obesity
- Improved NASH outcomes in C57BL6/J mice
- Lowered hepatic lipids
- Lowered liver weight
- Reduced biomarkers of liver injury (plasma ALT and AST)
- Decreased the inflammation marker galactin-3
- Reduced the fibrosis marker Col1a1
- Lowered the NAS score
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?